Gopi Shankar, Ph.D., MBA, FAAPS, is a distinguished professional serving as the Chief Development Officer at Larimar Therapeutics Inc. With an impressive educational background, Dr. Shankar holds a Ph.D. in Pharmaceutical Sciences and an MBA, which have equipped him with a unique blend of scientific and business acumen. He is also a Fellow of the American Association of Pharmaceutical Scientists (FAAPS), a testament to his expertise and contributions to the field of pharmaceuticals. Throughout his career, Dr. Shankar has held various leadership positions in the biopharmaceutical industry, where he has been instrumental in advancing drug development programs from early-stage research to clinical trials and eventual commercialization. His strategic vision and deep understanding of the regulatory landscape have enabled him to successfully navigate complex challenges and drive innovation. Dr. Shankar's notable achievements include leading cross-functional teams to develop novel therapies for rare diseases, securing significant funding for research initiatives, and forging strategic partnerships that have accelerated the development of life-changing treatments. As the Chief Development Officer at Larimar Therapeutics Inc., Dr. Shankar plays a pivotal role in overseeing the company's drug development strategy and execution. He leads efforts to advance Larimar's pipeline of innovative therapies, focusing on rare genetic disorders. Dr. Shankar's leadership is crucial in ensuring that Larimar's programs meet rigorous scientific and regulatory standards, ultimately aiming to bring transformative treatments to patients in need. His dedication to improving patient outcomes and his ability to foster a culture of excellence make him an invaluable asset to Larimar Therapeutics Inc.